Pages that link to "Q44840291"

The following pages link to Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons (Q44840291):

Displaying 26 items.

• MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells (Q21133026) (← links)
• HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination (Q24670026) (← links)
• Lung cancer-initiating cells: a novel target for cancer therapy (Q26824222) (← links)
• E2F1 in melanoma progression and metastasis (Q28268420) (← links)
• Rad5 template switch pathway of DNA damage tolerance determines synergism between cisplatin and NSC109268 in Saccharomyces cerevisiae (Q28534339) (← links)
• Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex/cyclosome. (Q30610162) (← links)
• Prediction of chromosomal aneuploidy from gene expression data. (Q31067056) (← links)
• Loss of the eukaryotic initiation factor 3f in pancreatic cancer (Q33301656) (← links)
• Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis (Q33657413) (← links)
• A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis (Q33811711) (← links)
• Overexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinoma (Q34984438) (← links)
• MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases (Q36798895) (← links)
• Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression (Q36850367) (← links)
• Loss of the eukaryotic initiation factor 3f in melanoma (Q37083955) (← links)
• Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA. (Q37261476) (← links)
• Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer (Q37344480) (← links)
• rs35301225 polymorphism in miR-34a promotes development of human colon cancer by deregulation of 3'UTR in E2F1 in Chinese population (Q37692620) (← links)
• Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 function (Q37809859) (← links)
• Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy? (Q38237693) (← links)
• Small compound bigelovin exerts inhibitory effects and triggers proteolysis of E2F1 in multiple myeloma cells. (Q39080639) (← links)
• E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer (Q41007502) (← links)
• E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy (Q42748851) (← links)
• E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma (Q43537069) (← links)
• MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer (Q44542942) (← links)
• G1/S arrest induced by histone deacetylase inhibitor sodium butyrate in E1A + Ras-transformed cells is mediated through down-regulation of E2F activity and stabilization of beta-catenin. (Q53621630) (← links)
• Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays (Q58051484) (← links)